Study of Muscle, Mobility and Aging (SOMMA)

肌肉、活动能力和衰老研究 (SOMMA)

基本信息

项目摘要

Mobility inevitably declines with age, more in some than other people, often leading to mobility disability with dependency, decreased quality of life, and enormous health care costs. The role of age-related biological changes in skeletal muscle on the decline in mobility is poorly understood. We hypothesize that muscle mass and the capacity to produce ATP are strong determinants of the mobility disability in older adults. Based on advances from laboratory studies of muscle aging, we also hypothesize that denervation, oxidative damage, and decreased autophagic flux interact and contribute to declines in fitness, endurance and an increased risk of mobility disability. We will also use transcriptomic profiling by RNAseq to discover patterns of gene expression that play important roles in the loss of mobility with aging. In the Study of Muscle Mobility and Aging (SOMMA), a prospective, longitudinal study of men and women age 70 to 90, our team of experts in clinical and laboratory sciences will use innovative and state-of- the-art technologies with rigorous quality control to test these hypotheses and discover new pathways for the loss of mobility with aging. We will measure quadriceps contractile volume by MRI and total muscle mass by d3 creatine dilution. We will use 31PMRS to assess the capacity of the quadriceps to generate ATP (ATPmax). In tissue form, muscle biopsies quantify denervation and oxidative damage to contractile proteins. SOMMA will be the first to quantify autophagic flux to assess the role of autophagy in the loss of mobility with aging. We use respirometry on fresh tissue to quantify the contribution of mitochondria to ATPmax and mobility disability. These properties interact: for example, decreased autophagic flux promotes the accumulation of oxidative damage and denervation, and understanding these relationships will guide the analysis and interpretation of our results. Furthermore, we will use unbiased RNA-sequencing (RNA-seq) to profile the entire transcriptome to discover new associations between clusters of genes and individual variation in rates of loss of fitness (peak VO2), muscle mass, and risk of mobility disability. Field centers at Wake Forest and Pittsburgh, with exceptional track records for recruiting and retaining older adults in complex studies, will enroll 875 women and men age 70–89 with a gait speed ≤ 1.0 m/s, providing sufficient power to identify important relationships between individual and combinations of properties and the risk of mobility disability. SOMMA may identify and prioritize targets for new therapeutics and tailored exercise regimens. We also will create a unique archive of tissue, blood, with longitudinal data about important clinical outcomes that the scientific community can use to efficiently test new hypotheses about muscle and loss of mobility with aging.
行动能力不可避免地会随着年龄的增长而下降,一些人的情况比另一些人更严重,这往往会导致行动不便 依赖,生活质量下降,以及巨大的医疗费用。年龄相关生物学的作用 骨骼肌的变化对运动能力下降的影响知之甚少。我们假设肌肉质量 产生三磷酸腺苷的能力是老年人行动能力障碍的重要决定因素。基于 从肌肉老化的实验室研究进展,我们还假设去神经,氧化损伤, 而自噬通量的减少相互作用,导致体能、耐力下降和风险增加 行动不便的人。我们还将使用RNAseq的转录图谱来发现基因模式 在随着年龄增长而丧失行动能力的过程中发挥重要作用的表达。 在肌肉运动和衰老研究(Somma)中,对男性和 年龄在70岁到90岁之间的女性,我们的临床和实验室科学专家团队将使用创新和最新的 具有严格质量控制的尖端技术,以检验这些假设并发现 随着年龄的增长,行动不便。我们将通过MRI测量股四头肌的收缩体积,通过 D3肌酸稀释。我们将使用31PMRS来评估股四头肌产生ATP的能力(ATPmax)。 在组织形式中,肌肉活组织检查量化了去神经和对收缩蛋白的氧化损伤。Somma将会 是第一个量化自噬通量的人,以评估自噬在随着年龄增长而丧失机动性方面的作用。我们用 对新鲜组织进行呼吸测量,以量化线粒体对ATPmax和行动障碍的贡献。 这些特性相互作用:例如,自噬通量的减少促进了氧化的积累 损伤和失神经,并了解这些关系将指导分析和解释 我们的结果。此外,我们将使用无偏rna测序(rna-seq)来描述整个转录组。 发现基因簇和个体适应度损失率变异之间的新关联(峰值 VO2)、肌肉质量和行动不便的风险。 位于维克森林和匹兹堡的外地中心,在招聘和留住方面有出色的记录 复杂研究中的老年人,将招收年龄在70-89岁的875名男女,步速≤为1米/S, 提供足够的能力来识别单个属性和属性组合之间的重要关系 以及行动不便的风险。 Somma可能会确定新疗法和量身定做的运动养生法的目标并确定其优先顺序。我们 还将创建一个独特的组织、血液档案,其中包含关于重要临床结果的纵向数据 科学界可以用来有效地测试关于肌肉和活动能力丧失的新假说 衰老。

项目成果

期刊论文数量(6)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The cellular bases of mobility from the Study of Muscle, Mobility and Aging (SOMMA).
来自肌肉、活动性和衰老研究 (SOMMA) 的活动性细胞基础。
  • DOI:
    10.1111/acel.14129
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    7.8
  • 作者:
    Cummings,StevenR;Coen,PaulM;Ferrucci,Luigi
  • 通讯作者:
    Ferrucci,Luigi
Autophagy gene expression in skeletal muscle of older individuals is associated with physical performance, muscle volume and mitochondrial function in the Study of Muscle, Mobility and Aging (SOMMA).
在肌肉、活动性和衰老研究 (SOMMA) 中,老年人骨骼肌中的自噬基因表达与身体表现、肌肉体积和线粒体功能相关。
  • DOI:
    10.1101/2023.11.04.23297979
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Coen,PaulM;Huo,Zhiguang;Tranah,GregoryJ;Barnes,HaleyN;Cawthon,PeggyM;Hepple,RussellT;Toledo,FredericoGS;Evans,DanielS;Fernández,OlayaSantiago;Cuervo,AnaMaria;Kritchevsky,StevenB;Newman,AnneB;Cummings,StevenR;Esser,K
  • 通讯作者:
    Esser,K
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

STEVEN RON CUMMINGS其他文献

STEVEN RON CUMMINGS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('STEVEN RON CUMMINGS', 18)}}的其他基金

Study of Muscle, Mobility and Aging (SOMMA)
肌肉、活动能力和衰老研究 (SOMMA)
  • 批准号:
    10170192
  • 财政年份:
    2018
  • 资助金额:
    $ 24.55万
  • 项目类别:
Prevention of Fractures in Patients with Parkinson's Disease
帕金森病患者骨折的预防
  • 批准号:
    10617169
  • 财政年份:
    2018
  • 资助金额:
    $ 24.55万
  • 项目类别:
Study of Muscle, Mobility and Aging: SOMMA2
肌肉、活动能力和衰老研究:SOMMA2
  • 批准号:
    10913728
  • 财政年份:
    2018
  • 资助金额:
    $ 24.55万
  • 项目类别:
SOMMA-BRAIN
索玛脑
  • 批准号:
    10065711
  • 财政年份:
    2018
  • 资助金额:
    $ 24.55万
  • 项目类别:
Study of Muscle, Mobility and Aging (SOMMA)
肌肉、活动能力和衰老研究 (SOMMA)
  • 批准号:
    10441623
  • 财政年份:
    2018
  • 资助金额:
    $ 24.55万
  • 项目类别:
Study of Muscle, Mobility and Aging (SOMMA)
肌肉、活动能力和衰老研究 (SOMMA)
  • 批准号:
    10015194
  • 财政年份:
    2018
  • 资助金额:
    $ 24.55万
  • 项目类别:
Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins
衰老相关临床结果和Gero蛋白的综合评价
  • 批准号:
    9519838
  • 财政年份:
    2016
  • 资助金额:
    $ 24.55万
  • 项目类别:
Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins
衰老相关临床结果和Gero蛋白的综合评价
  • 批准号:
    9279037
  • 财政年份:
    2016
  • 资助金额:
    $ 24.55万
  • 项目类别:
Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins - SUPPLEMENT
衰老相关临床结果和老年蛋白的综合评估 - 补充材料
  • 批准号:
    9445352
  • 财政年份:
    2016
  • 资助金额:
    $ 24.55万
  • 项目类别:
Comprehensive Evaluation of Aging-Related Clinical Outcomes and Geroproteins
衰老相关临床结果和Gero蛋白的综合评价
  • 批准号:
    9119555
  • 财政年份:
    2016
  • 资助金额:
    $ 24.55万
  • 项目类别:

相似海外基金

A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
Sedentary behavior, physical activity, and 24-hour behavior in pregnancy and offspring health: the Pregnancy 24/7 Offspring Study Administrative Supplement
久坐行为、体力活动和 24 小时行为对怀孕和后代健康的影响:怀孕 24/7 后代研究行政补充
  • 批准号:
    10893074
  • 财政年份:
    2023
  • 资助金额:
    $ 24.55万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了